Davion Healthcare Plc Ordinary Shares（DAVI）股票分析

AI 分析 of Davion Healthcare Plc Ordinary Shares (DAVI)

卖出

Daviion Healthcare Plc is not a good buy right now due to its significant decline in value and lack of positive financial indicators. The stock has dropped 89.17% year-to-date and is currently trading at $1.49, which is very close to its 52-week low of $1.46. Additionally, the company has a price-to-book ratio of 31.6019, indicating it is highly overvalued compared to its assets. The recent acquisitions may provide some future potential, but the current performance and high risk outweigh these factors.

估值指标

Davion Healthcare Plc Ordinary Shares（DAVI）当前预期市盈率为 0.00，5 年平均预期市盈率为。

预期市盈率

5 年均值 P/E

当前P/E

0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA

当前EV/EBITDA

0.00

预期市销率

5 年均值 P/S

当前P/S

0.00

DAVI 常见问题 —— 由 Alphio AI 解答

Daviion Healthcare Plc is not a good buy right now due to its significant decline in value and lack of positive financial indicators. The stock has dropped 89.17% year-to-date and is currently trading at $1.49, which is very close to its 52-week low of $1.46. Additionally, the company has a price-to-book ratio of 31.6019, indicating it is highly overvalued compared to its assets. The recent acquisitions may provide some future potential, but the current performance and high risk outweigh these factors.

Davion Healthcare Plc Ordinary Shares（DAVI）股票分析

AI 分析 of Davion Healthcare Plc Ordinary Shares (DAVI)

估值指标

预期市盈率

预期 EV/EBITDA

预期市销率

资讯

DAVI 常见问题 —— 由 Alphio AI 解答

社区

相关文章